The promyelocytic leukemia protein (PML) is a tumor suppressor that is expressed at a low level in various cancers. Although post-translational modifications including SUMOylation, phosphorylation, and ubiquitination have been found to regulate the stability or activity of PML, little is known about the role of its acetylation in the control of cell survival. Here we demonstrate that acetylation of lysine 487 (K487) and SUMO1 conjugation of K490 at PML protein are mutually exclusive. We found that hydrogen peroxide (H 2 O 2 ) promotes PML deacetylation and identified SIRT1 and SIRT5 as PML deacetylases. Both SIRT1 and SIRT5 are required for H 2 O 2 -mediated deacetylation of PML and accumulation of nuclear PML protein in HeLa cells. Knockdown of SIRT1 reduces the number of H 2 O 2 -induced PML-nuclear bodies (NBs) and increases the survival of HeLa cells. Ectopic expression of wild-type PML but not the K487R mutant rescues H 2 O 2 -induced cell death in SIRT1 knockdown cells. Furthermore, ectopic expression of wild-type SIRT5 but not a catalytic defective mutant can also restore H 2 O 2 -induced cell death in SIRT1 knockdown cells. Taken together, our findings reveal a novel regulatory mechanism in which SIRT1/SIRT5-mediated PML deacetylation plays a role in the regulation of cancer cell survival. Cell Death and Disease (2014) 5, e1340; doi:10.1038/cddis.2014.185; published online 17 July 2014
important functions in aging, metabolism, and cancer. 18, 19 Emerging evidence has shown that SIRT1 positively or negatively modulates tumorigenesis, depending on the context. 20 The differential subcellular localization of SIRT1 in normal and cancer cells may affect substrate accessibility and partially account for the contrasting roles of SIRT1 in tumorigenesis. 21, 22 For example, SIRT1 is mainly localized in the nucleus of normal cells, whereas it is predominately localized in the cytoplasm in cancer or transformed cells. 23, 24 Nuclear SIRT1 deacetylates and inactivates transcription factors, including NF-kB (nuclear factor k-light-chain-enhancer of activated B cells), STAT3 (signal transducer and activator of transcription 3), and HIF-1a (hypoxia-inducible factor-1a), [25] [26] [27] exerting anti-inflammatory and anticarcinogenic effects. Moreover, nuclear SIRT1 reduces DNA damage and maintains genomic integrity by deacetylating DNA repair proteins, for example, poly(ADP-ribose) polymerase 1 (PARP1), xeroderma pigmentosum C (XPC), and Nijmegen breakage syndrome protein 1 (NBS1). [28] [29] [30] In contrast, cytoplasmic SIRT1 deacetylates and activates the oncoprotein Akt 31 and stabilizes c-Myc protein. 32 SIRT1 has also been reported to deacetylate p53, retinoblastoma (Rb) 33, 34 and PTEN (phosphatase and tensin homolog), 35 inactivating their tumor suppressive activity. Unlike SIRT1, SIRT5 is less well characterized and only carbamoyl phosphate synthetase 1 (CPS1) has been functionally identified as a SIRT5 substrate. 36 A recent study showed that SIRT5 is significantly downregulated in neck squamous cancerous tissues compared with noncancerous tissues. It is also downregulated in advanced stages compared with early stages of the disease, 37 implying that it acts as a tumor suppressor.
PTMs, such as SUMOylation, phosphorylation, and ubiquitination, have been found to regulate the tumor suppressor function of PML, but little is known about its acetylation. In addition to SIRT1, we have identified SIRT5 as a novel interacting partner of PML and demonstrated that nuclear SIRT1 and SIRT5 increase accumulation of PML-NBs and that this activity is dependent on their deacetylase activity. This regulation may play an important role in H 2 O 2 -induced cell death. Thus, our current work has elucidated a novel regulation of PML protein and uncovered potential opportunities for therapeutic intervention by targeting PML regulators, SIRT1, and SIRT5.
Results
H 2 O 2 stimulates PML-NB accumulation and PML deacetylation. H 2 O 2 has attracted increasing attention as a molecule that regulates fundamental biological processes and pathological progression, including angiogenesis, oxidative stress, aging, and cancer. 38, 39 To study the effects of H 2 O 2 on PML, we treated HeLa cells with H 2 O 2 and examined subcellular distribution of PML by immunofluorescence microscopy. We found that H 2 O 2 induced nuclear accumulation of PML and increased PML-NB number (Figures 1a and b ). The increase in nuclear PML and PML-NBs in response to H 2 O 2 is accompanied by a decrease in cytoplasmic PML in H 2 O 2 -treated cells (Figure 1c ).
To determine whether acetylation status of PML was altered in response to H 2 O 2 , HeLa cells were treated with H 2 O 2 , harvested, and followed by immunoprecipitation with anti-PML antibody and immunoblotting with anti-acetyl-lysine and anti-PML antibodies. We found that acetylation of endogenous and transfected PML was decreased in H 2 O 2 -treated cells (Figures 1d and e) . Taken together, we conclude that H 2 O 2 promotes accumulation of nuclear PML and PMLNBs and decreases PML acetylation.
SIRT1 and SIRT5 interact and deacelylate PML at lysine 487. We next determined which deacetylase is capable of deacetylating PML. We examined PML acetylation status after co-transfecting epitope-tagged PML4 with plasmids expressing class I, II or III histone deacetylases, all of which also deacetylate nonhistone proteins. Through this screening, SIRT1 and SIRT5 were found to promote PML4 deacetylation ( Figure 1f and Supplementary Figure 1) . We further determined that both SIRT1 and SIRT5 promote deacetylation of other nuclear PML isoforms in HeLa cells ( Supplementary Figures 2A-E) and deacetylation of PML4 in HCT116 p53
À / À cells (Supplementary Figure 2F) . To determine whether PML deacetylation is dependent on SIRT1/SIRT5 catalytic activity, HeLa cells were co-transfected with HA-PML4 and wild-type SIRT1, SIRT5, or catalytically impaired mutants, SIRT1 (H363Y) or SIRT5 (H158Y). We found that PML acetylation was significantly abolished by coexpression with the wild-type SIRT1 or SIRT5, but not catalytically defective mutants, SIRT1 (H363Y) or SIRT5 (H158Y) (Figures 2a and b) . Conversely, knockdown of SIRT1 or SIRT5 modestly increased PML4 acetylation (Figures 2c and d and Supplementary Figure 2G ). Moreover, double knockdown of SIRT1 and SIRT5 dramatically increased PML acetylation (Figure 2e ). We further demonstrated that either endogenous or transfected SIRT1 and SIRT5 associate with PML (Figures 2f-i) .
PML has two potential acetylation sites, K487 and K515. 14, 40 To determine which residues are deacetylated by SIRT1, we generated single and double PML mutants, K487R, K515R, and K487/515R, in which lysine was substituted by arginine. Compared with wild-type PML, the K487R and K487/515R mutants were barely acetylated (Figure 3a ). In contrast, there was no significant change in acetylation in the K515R mutant. We co-transfected PML (K515R) with wild-type SIRT1 or the catalytically impaired mutant SIRT1, H363Y, and found that the acetylation level of PML (K515R) was significant decreased by wild-type SIRT1 but not by the catalytically impaired mutant SIRT1 (H363Y) (Figure 3b ). These date indicate that lysine 487 of PML is a target for SIRT1 deacetylation.
K487 is located within a functional nuclear localization sequence (NLS) in PML. To determine the effect of K487 on PML subcellular distribution, we transfected HeLa cells with wild-type, K487R, K515R and K487/515R PML, and visualized PML subcellular distribution by immunofluorescence microscopy. We found that PML4 (K487R and K487/515R) mutants were mostly located in the cytoplasm (Figure 3c ). To determine whether the cytoplasmic localization of PML4 (K487R) is isoform specific, we introduced K487R and K515R mutations into two other commonly studied PML isoforms, PML1 and PML6. Similar to PML4 (K487R), PML1 (K487R) and PML6 (K487R) showed exclusive cytoplasmic localization (Supplementary Figure 3) . These results indicate that K487 is an important acetylation site in PML, which can be targeted by SIRT1, and is essential for nuclear localization of PML.
Crosstalk between K487 acetylation and K490 SUMOylation. SUMOylation of PML primarily occurs at K65, K160, and K490. 7 To examine the SUMOylation status of each site, we constructed hemagglutinin (HA)-tagged PML4 mutants in which only a single lysine is available for SUMOylation, namely K65/160R, K65/490R, and K160/490R. In order to study protein SUMOylation, N-ethylmaleimide (NEM) was added in the lysis buffer to inhibit SUMO peptidase activity. We found that the SUMO1 conjugation at K490 was significantly increased in mutant PML (K65 and K160) (Figure 4a , lane 1 versus lane 2), whereas SUMO1 conjugation at K65 and K160 was almost undetectable. Our observation that K487 is acetylated raised the possibility that acetylation at lysine 487 affects SUMO1 conjugation at K490 or vice versa. Because PML (K487R) is exclusively cytoplasmic, we first rescued the nuclear localization of PML (K487R) by adding a NLS sequence derived from SV40 T antigen at the N-terminus of wild-type and K487R mutant. As expected, PML (NLS-K487R) forms similar PML-NBs as the wild-type protein (Figure 4b) , and exhibits no detectable acetylation (Figure 4c ). Interestingly, we found that mutant PML (K487R) is devoid of SUMO1 conjugation, but NLS-K487R is SUMO1 conjugated (Figure 4d ). Taken together, we conclude that K490 is an To further dissect the crosstalk between K487 acetylation and K490 SUMO1 conjugation, we focused on nuclear PML because SUMO1 conjugation at K490 only occurs in the nucleus (Figure 4d ). We generated constitutive nuclear PML by adding an NLS at the N-terminus. We co-transfected PML (NLS-HA-K65/160R) and FLAG-SUMO1 with empty vector, wild-type Myc-SIRT1, or the catalytically impaired mutant Myc-SIRT1 (H363Y) into HeLa cells. As shown in Figure 5a , ). These data suggest that deacetylation of PML K487 by SIRT1 increases SUMO1 modification on PML K490. We further examined whether SIRT1 plays a role in the crosstalk between K487 acetylation and K490 SUMO1 conjugation. As shown in Figure 5c , we found no significant differences of acetylation or SUMO1 modification of PML (NLS-K65/160R) in control and SIRT1 knockdown cells. We next asked whether this lack of regulation of PML acetylation and SUMOylation by SIRT1 was due to different subcellular localizations of SIRT1 and PML (NLS-K65/160R) in HeLa cells. SIRT1 is primarily localized in the cytoplasm of HeLa cells, whereas PML (NLS-K65/160R) is exclusively nuclear. It has been reported that H 2 O 2 induces nuclear translocation of SIRT1. 38 Indeed, we observed an increase in acetylation and a decrease in SUMO1 conjugation of PML (NLS-K65/160R) in SIRT1 knockdown HeLa cells upon H 2 O 2 treatment (Figures 5d and e).
Lysine acetylation functions by generating a site for specific recognition by cellular factors or by neutralizing positive charges. The lysine-to-arginine (K/R) substitution prevents acetylation but maintains the same positive charge, thus mimicking the nonacetylated form. In contrast, lysine-toglutamine (K/Q) substitutions mimic the constitutively acetylated form through neutralization of positive charge. 41, 42 To elucidate the mechanism by which K487 acetylation inhibits K490 SUMO1 conjugation, HeLa cells were transfected with HA-tagged PML (NLS-K65/160R), PML (NLS-K65/160/ 487R), PML (NLS-K65/160R/K487Q), or PML (K65/160/ 490R). The latter was used as a negative control for SUMOylation, with (Figure 5f We also examined whether K490 SUMO modification affects K487 acetylation. We transfected HeLa cells with the HA-tagged PML4 mutants, K65/160R, K65/490R, and K160/ 490R, in which only single lysine is available for SUMO conjugation. We found that mutants bearing K490R, which abolishes SUMO1 modification, exhibited increased acetylation ( Figure 4h, lanes 3-5) . These data suggest that the K490 SUMO1 modification prevents K487 from acetylation. In sum, these results indicate that K487 acetylation and K490 SUMOylation mutually inhibit each other.
Depletion of SIRT1 attenuates H 2 O 2 -induced accumulation of PML-NBs and cell death. To test whether H 2 O 2 promotes nuclear accumulation of SIRT1, we performed a subcellular fractionation experiment. As expected, western blot analysis of the whole-cell extracts and nuclear extracts revealed that H 2 O 2 treatment led to an accumulation of nuclear SIRT1 in a dose-dependent manner but did not affect total SIRT1 protein level (Figure 6a ). Because H 2 O 2 promotes nuclear accumulation of both SIRT1 and PML, we sought to determine whether SIRT1 is required for (Figures 6g and h) .
Evidence, including ours, has shown that downregulation of PML reduces sensitivity to H 2 O 2 -induced cell death. 11, 43 Because knockdown of SIRT1 reduces the accumulation of PML-NBs, we speculated that SIRT1 knockdown HeLa cells will be resistant to H 2 O 2 -induced cell death. To test this, we measured cell viability of control and SIRT1 knockdown HeLa cells in response to H 2 O 2 ( Figure 7a) . We found that H 2 O 2 treatment led to significant cell death of control cells but not SIRT1 knockdown cells (Figure 7a, lane 4 versus lane 1) . We further verified the above data by colony formation assays and obtained similar results (Figures 7b and c) (Figure 7d, lanes 1-4) . However, this rescue effect of overexpression of SIRT5 was largely dependent on the presence of PML (Figure 7d, lanes 5-8) . As a control for the experiment, the expression levels of PML, SIRT1, and SIRT5 proteins were examined by western blotting (Figure 7d) . In summary, these data strongly suggest that resistance to H 2 O 2 treatment in SIRT1-depleted cells is due, in part, to change in acetylation status of PML.
Discussion
In response to diverse extracellular stimuli, PML protein is post-translationally modified to control its activity, stability, and subcellular localization. In the present study, we found that the acetylation of PML was downregulated in response to H 2 O 2 treatment, and identified SIRT1 and SIRT5 as deacetylases that are capable of deacetylating PML at K487. When lysine 487 is substituted by arginine (K487R), PML-NBs are restricted to the cytoplasm (Figure 3c ), an observation similar to previous reports. 44, 45 The oncogenic function of cytoplasmic PML was reported to correlate with redistributing nuclear PML to the cytoplasm, thus reducing the number of PML-NBs and inhibiting cell apoptosis, and promoting proliferation. 40, 44, 46, 47 Similarly, we found that SIRT1 knockdown HeLa cells, where the numbers of PML-NBs are markedly downregulated, are resistant to H 2 O 2 -induced cell death. Ectopic overexpression of wild-type PML, which forms PMLNBs, significantly rescued the resistance to H 2 O 2 -induced cell death in SIRT1 knockdown HeLa cells, but not the cytoplasmic mutant PML (K487R) (Figures 7a-c) . Consistently, wildtype SIRT5, which deacetylates PML in SIRT1 knockdown HeLa cells and promotes accumulation of PML-NBs, also partially rescued the resistance to H 2 O 2 -induced cell death of SIRT1 knockdown cells (Figures 6f and 7d) .
Our work also highlights a novel post-translational crosstalk between PML acetylation at K487 and SUMO1 conjugation at K490 (Figure 7e) . The interplay of different PTMs has emerged as key mechanism for dynamic control of cellular signaling. 15 Acetylation neutralizes the positive charge of lysine, which may disrupt protein interaction, 48 including enzymes that affect modification of neighboring sites, and NLS binding to the translocation machinery. Several lines of evidence suggest that K487 acetylation blocks K490 SUMO1 conjugation. First, overexpression of SIRT1, the deacetylase for PML K487, enhanced SUMO1 modification at K490 (Figures 5a and b) , whereas knockdown of SIRT1 reduced it. We also noted that the sizes of SUMO1 modified PML and acetylated PML are different (Figures 5a and b) . Furthermore, SUMO1 conjugation at K490 in PML (NLS-K65/160R) is reduced in K487Q mutant, a negatively charged amino acid that mimics the acetylated form (Figures 5c-g ). Taken together, these observations indicated that K487 acetylation and K490 SUMO1 conjugation are mutually exclusive. Acetylation blocking SUMOlyation is not due to same site exclusion, although K487 and K490 are close to each other. Perhaps proximity of the two modification sites is important. Interestingly, SUMOylation of K490 also inhibits PML acetylation, presumably at K487 (Figure 5h) . SUMOylation of histone/nonhistone proteins can lead to the recruitment of HDACs.
49,50 However, we did not observe significant differences between the interactions of GST-SIRT1/5 with non-SUMO1-conjugated and SUMO1-conjugated PML (data not shown). Our findings raise the possibility of whether such regulation is unique to PML. To address this issue, we performed sequence analysis of known acetylated peptides. 16 Combining the known acetylated peptide sequences and the well-established SUMO conjugation motif, KXE, we hypothesize that a putative sequence motif, KXXKXE, may be regulated by the crosstalk described in this study (Figure 8a ). For example, the nuclear receptor coactivator 2 (NCOA2/GRIP1) has been reported to be acetylated at K785, 16 and SUMO1 conjugated at K788. 51 We have also identified several proteins that are acetylated within this putative motif. It would be interesting to see whether the second lysine in this motif is SUMOylated and whether there is a similar crosstalk between acetylation and SUMOylation in these proteins.
Since the identification of CPS1 as a SIRT5 deacetylation target from mouse mitochondria matrix lysates, 36 most studies have focused on the function of SIRT5 in mitochondria. From our biochemical deacetylase screen, we functionally identified PML as the first nonmitochondria protein substrate for SIRT5 deacetylation. One recent study also showed that SIRT5 is present extramitochondrially 52 that supports our observation that SIRT5 functionally regulates nonmitochondrial substrates such as PML. Consistent with these observations, a significant fraction of exogenously expressed SIRT5 is localized in the nucleus (Figures 6g and h) . Although SIRT1 and SIRT5 have distinct substrate specificities for p53-related substrates and CPS1, both can deacetylate PML. Indeed, overexpression of SIRT5 partially rescued PML function in SIRT1 knockdown cells when treated with H 2 O 2 ( Figure 7d ). Interestingly, both SIRT1 and SIRT5 express and behave similarly in response to caloric restriction 53 and are significantly downregulated in head and neck squamous cell carcinomas, 37 suggesting some level of common regulation and function for these two deacetylases.
We have previously shown that PML is required for H 2 O 2 -mediated cell death in MDA-MB-231 breast cancer cells. 54 In this study, we also demonstrated that SIRT1 is essential for H 2 O 2 -induced cell death in HeLa cervical cancer cells.
Notably, H 2 O 2 treatment promotes nuclear translocation of PML and formation of PML-NBs. Although the mechanism underlying H 2 O 2 -mediated PML nuclear translocation remains largely unknown, this activity is essential for H 2 O 2 -induced cell death because the loss of sensitivity to H 2 O 2 -induced cell death in SIRT1 knockdown cells can be rescued by overexpression of wild-type PML or NLS-K487R, but not the constitutively cytoplasmic mutant, K487R (Figure 7a ). These results imply that loss of nuclear PML contributes to the insensitivity of SIRT1 knockdown cells to H 2 O 2 -mediated cell death. In summary, we have identified SIRT1 and SIRT5 as PML deacetylases and established a novel post-translational crosstalk between K487 acetylation and K490 SUMO1 modification in PML. Finally, we describe a role of PML deacetylation in H 2 O 2 -induced cell death.
Materials and Methods
Cell culture and transfection. HeLa cells were maintained in DMEM (Dulbecco's modified Eagle's medium) (Cellgro, Herndon, VA, USA) supplemented with 10% fetal bovine serum and 50 units/ml penicillin and streptomycin sulfate. HCT 116 p53
À / À cells were maintained in McCoy's 5A (Cellgro) supplemented with 10% fetal bovine serum and 50 units/ml penicillin and streptomycin sulfate.
Control (scramble shRNA) and SIRT1 shRNA stable HeLa cell lines were cultured under the same conditions with the addition of 0.25 mg/ml of puromycin as previously described. 55 Transfections were performed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).
Antibodies, siRNA, and plasmids. Anti-PML, SIRT1, and SUMO1 rabbit polyclonal antibodies were purified in-house. The specificity of in-house anti-PML antibodies was validated previously in HUVECs 9 and in HeLa cells (Supplementary Figure 5) . The following antibodies were purchased: b-actin (A5441), a-tubulin (T6074), and FLAG (F1084) from Sigma (St Louis, MO, USA); HA-HRP (12013819001) from Roche Applied Science (Indianapolis, IN, USA); Myc (no. 2276) and Acetylated-Lysine (no. 9441) from Cell Signaling Technology (Danvers, MA, USA); lamin B (sc-6216) and mouse monoclonal anti-PML (sc-966, for immunofluorescence) from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Nontargeting control (D-001810-01) and PML (J-006547-03 and J-006547-05) siRNAs and transfection regent DharmaFECT1 (T-2001) were purchased from Thermo Scientific (Rockford, IL, USA). Nontargeting control (SHC002), SIRT1 (TRCN0000018981 and TRCN0000018983), and SIRT5 (TRCN0000018545 and TRCN0000018546) shRNA plasmids were purchased from Sigma. FLAG-SIRTs1-7, 55 Myc-SIRT1, Myc-SIRT1 (H363Y), FLAG-SIRT5, and FLAG-SIRT5 were subcloned into the pcDNA 3.1 plasmid. Other expression plasmids were subcloned into pCMX plasmid as previously described [9] [10] [11] [12] and mutants were generated by site-specific PCR mutagenesis and verified by sequencing. To construct NLS fusion PML protein, NLS derived from the simian virus 40 (SV40) large tumor antigen (PKKKRKV) was added at the N-terminus of HA-tagged wild-type and Figure 8 (a) An alignment of a putative sequence motif that are both acetylated and SUMO1 conjugated. This sequence motif is based on this study on the crosstalk between acetylation of K487 and SUMO1 conjugation at K490 of PML, the known acetylated peptide sequences that contain KXXK, 16 and the well-established SUMOylation motif, KXE. Note that some acetylated peptides contain KXK sequence (data not shown), and hence potentially KXKXE is a loosely conserved motif. (b) Proposed model summarizing the findings of this study. In HeLa cervical cancer cells, PML, SIRT1, and SIRT5 are predominantly localized in the cytoplasm, where PML is acetylated by HATs and deacetylated by SIRT1 and SIRT5. H 2 O 2 induce nuclear translocation of PML, SIRT1, and SIRT5. Deacetylation of PML ac-K487 by SIRT1 or SIRT5 is required for H 2 O 2 -induced SUMO1 conjugation of PML K490, formation of PML-NBs, and cell death mutant PML protein. CMX-HA-PML 1, 2, 3, and 5 were generated by PCR using pcDNA3-PML 1, 2, 3, and 5 (kindly provided by Kun-Sang Chang, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) as templates and subcloned into CMX-1H vector.
Immunofluorescence microscopy. Immunofluorescence microscopy was carried out as described previously 9, 10 with minor modifications. Primary antibody incubation with anti-PML and anti-HA was carried out at room temperature for 2 h. After washing, Alexa Fluor secondary antibodies (Invitrogen) were added and incubated for 40 min in the dark. Nuclei were counterstained with DAPI (Vector Laboratories, Burlingame, CA, USA). All fluorescence images were acquired using a Leica DMI 6000B inverted microscope or a confocal system (PerkinElmer, Waltham, MA, USA).
Immunoprecipitation and western blotting analysis. HeLa cells at 70-80% confluency, transfected with the indicated plasmids or treated with H 2 O 2 , were washed with 1 Â phosphate-buffered saline (PBS) and resuspended in RIPA buffer (1 Â PBS, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS) along with 1 Â protease inhibitor cocktail and phosphatases inhibitor cocktail (Roche Applied Science). To detect PML SUMOylation in HeLa cells, whole-cell extracts in the presence of NEM were prepared. Lysed cells were centrifuged at 41C at 12 000 r.p.m. for 10 min, and the supernatant was incubated with protein A-conjugated beads for preclearing. To detect protein-protein interactions or acetylation and SUMO1 modification of PML, whole-cell extracts were incubated with anti-HA antibody-conjugated beads (Sigma F2426) or anti-FLAG antibodyconjugated beads (Sigma E6779) for 2 h. The beads were washed with NETN buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 10% glycerol, 1 mM dithiothreitol, and 0.1% NP-40) five times, and supernatants were discarded. Then, 2 Â sample buffer was added to the beads, followed by SDS-PAGE and western blotting as previously described.
9,10
Fractionation of cytoplasmic and nuclear extracts. Nuclear and cytoplasmic fractionation has been described previously 38 with minor modifications. Briefly, cytoplasmic extracts were made by resuspending whole-cell pellets with cytosolic extraction buffer: CEBN (10 mM HEPES 7.8, 10 mM KCl, 2 mM MgCl 2 , 0.34 M sucrose, 10% glycerol, and 0.2% NP40/IPEGAL) for 10 min on ice followed by centrifugation at 2000 Â g for 5 min at 41C. The nuclear pellets were then washed once with CEB buffer (CEBN buffer without NP-40), pelleted, resuspended in 2 Â sample buffer, and sheared by sonication. The cytoplasmic and nuclear extracts were analyzed by western blotting with the indicated antibodies. For colony formation assay, 2 Â 10 3 cells were seeded into 100-mm tissue culture plate. After 12 h, the cells were treated with 8 mM H 2 O 2 for 1 h, washed, and incubated with fresh media. After 9 days, when macroscopic colonies became detectable, the cells were washed with PBS and stained with crystal violet and the number of colonies scored. Each experiment was carried out in triplicate.
Statistical analysis. Statistical analysis was performed using two-tailed Student's t-test, using Po0.05 as a criterion of significance.
